ADGM Share Price Performance
US$0.91
-1.69 (-64.99%)
Price US$0.91
Share PriceUS$0.91
Adagio Medical Holdings, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
ADGM Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Adagio Medical Holdings, Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -4.79
- -735.09%
- -22,875.16%
- 195.5%
About ADGM
- Founded
- 2011
- Employees
- 80
- CEO
- WebsiteView website
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
